Biomatics Capital Partners closed its second fund focused on breakthrough science and technology in health care, bringing in $300m to fund the development of therapeutics, diagnostics, research and development tools, and digital health.
Biomatics Managing Director Julie Sunderland told Scrip that the second fund will follow the same overarching investment thesis as the...






